Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (6.098%)
Market Cap: £12.26m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Sch 1 Update - Ingenta plc

14 Feb 2007 11:02

AIM14 February 2007 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Ingenta plc (to be renamed Publishing Technology plc on re-Admission) COMPANY ADDRESS:Unipart House Garsington Road Oxford COMPANY POSTCODE:OX4 2GQ COUNTRY OF INCORPORATION:England & Wales COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:The Company and its subsidiaries (the "Group") currently provides a suite of services for publishers of content,including data conversion, secure online hosting, access control, distribution and marketing services andinformation commerce systems. Following the proposed acquisition of Vista International Limited, the Group willalso become a supplier of software solutions and related professional and customer services to the North Americanand European book and journal publishing industry. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):186,207,420 existing Ordinary Shares of 1p each to be re-admitted 150,000,000 new Ordinary Shares of 1p each to be admitted (by way of placing and subscription) 260,000,000 new Ordinary Shares of 1p each to be admitted (as vendor consideration) CAPITAL TO BE RAISED ON ADMISSION:£1.5 million FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Pre-Admission: Martyn Craig Rose (Non-executive Chairman) Simon James Francis Dessain (Chief Executive) Mark Alexander Rowse (Non Executive Director) Ward Shaw (Non Executive Director) On re-Admission: Martyn Craig Rose (Non-executive Chairman) George Michael Lossius (Chief Executive) Simon James Francis Dessain (Chief Operating Officer) Alan Boyd Moug (Chief Financial Officer) Mark Alexander Rowse (Non Executive Director) Ward Shaw (Non Executive Director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION: Percentage holding before admission Martyn Rose 4% Mark Rowse 7.6% Cazenove Fund Management 12.3% Percentage holding after admission Martyn Rose 16.2% Mark Rowse 4.7% Alan Moug 6.4% George Lossius 6.3% Almandine LLC 7.0% Spread Trustee Limited 6.4% Brian Gibson 6.3% Colin Bottle 5.2% Cazenove Fund Management 8.9% NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:N/A ANTICIPATED ACCOUNTING REFERENCE DATE:31 December EXPECTED ADMISSION DATE:28 February 2007 NAME AND ADDRESS OF NOMINATED ADVISER:Collins Stewart Europe Limited, 9th Floor, 88 Wood Street, London EC2V 7QRNAME AND ADDRESS OF BROKER:Collins Stewart Europe Limited, 9th Floor, 88 Wood Street, London EC2V 7QRDETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENTTHAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:The Admission Document will be available from the offices of Collins Stewart Europe Limited, 9th Floor, 88 WoodStreet, London EC2V 7QR and will contain full details about the applicant and the admission of its securitiesDATE OF NOTIFICATION:14 February 2007 NEW/ UPDATE (see note):UPDATE This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jun 20267:00 amRNSAGM Trading Update
1st May 20267:01 amRNS-RInvestor Presentation via Investor Meet Company
1st May 20267:00 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20267:00 amRNSFinal Results
22nd Jan 20267:00 amRNSTrading Update
18th Nov 20254:30 pmRNSHolding(s) in Company
18th Nov 20254:29 pmRNSHolding(s) in Company
4th Nov 20253:21 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20255:27 pmRNSHolding(s) in Company
18th Sep 202511:00 amRNSInvestor Presentation via Investor Meet Company
15th Sep 20257:00 amRNSHalf-year Report
26th Jun 20254:42 pmRNSResult of Annual General Meeting
7th May 20254:54 pmRNSPosting of Annual Report & Notice of AGM
28th Apr 20257:00 amRNSFinal Results
7th Feb 20257:00 amRNSTrading Update
15th Nov 20244:52 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSHalf-year Report
18th Jul 20244:42 pmRNSResult of AGM and Directorate Change
3rd Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20244:30 pmRNSPosting of Annual Report & Notice of AGM
3rd Jun 20247:00 amRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
28th May 20247:00 amRNSFinal Results
17th May 20242:20 pmRNSFinal Results Update
31st Jan 20247:00 amRNSTrading Update
25th Oct 20233:57 pmRNSChange of Nomad and Broker
17th Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSNew customer wins
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20232:44 pmRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Update
29th Jun 202312:52 pmRNSResult of AGM & Dividend Timetable
29th Jun 20237:00 amRNSAGM statement and contract wins
25th May 20234:00 pmRNSPosting of Annual Report & Notice of AGM
17th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Final Results
2nd Feb 20237:00 amRNSTrading Update
2nd Dec 20226:02 pmRNSDirector/PDMR Shareholding
16th Nov 20224:31 pmRNSHolding(s) in Company
14th Nov 20223:57 pmRNSResult of Tender Offer
11th Nov 202211:24 amRNSResult of General Meeting
25th Oct 20227:00 amRNSProposed Tender Offer & Notice of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20222:09 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSTrading Update
28th Jul 20223:02 pmRNSResult of AGM and Dividend Timetable
8th Jul 20227:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.